umbilical cord blood-derived allogeneic leukocyte therapy (University of Queensland/CCRM)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameumbilical cord blood-derived allogeneic leukocyte therapy (University of Queensland/CCRM)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Leukocyte cell therapy
Mechanisms of ActionNeutrophils stimulants
TargetsUpdating
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentre for Commercialization of Regenerative MedicineThe University Of Queensland
Active IndicationsN/A
Inactive IndicationsNeutropenia

Other Information

ATC CodeN/A
Related LinksN/A